Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation

Journal of Virology

Volumn 81, Issue 20, 2007, Pages 11236-11245

  Wu, Yi ^a   Maruo, Seiji ^a   Yajima, Misako ^a   Kanda, Teru ^a   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN BARR VIRUS ENCODED RNA 2; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VIRUS RNA;

ARTICLE; B LYMPHOCYTE; CELL DENSITY; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; LYMPHOBLASTOID CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS RECOMBINANT;

B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-6; RNA, VIRAL;

HUMAN HERPESVIRUS 4;

EID: 35148848613     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00579-07     Document Type: Article

References (40)

1. Aparicio, O., N. Razquin, M. Zaratiegui, I. Narvaiza, and P. Fortes. 2006. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J. Virol. 80:1376-1384.
2. Arrand, J. R., L. S. Young, and J. D. Tugwood. 1989. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J. Virol. 63:983-986.
3. Clarke, P. A., M. Schwemmte, J. Schickinger, K. Hilse, and M. J. Clemens. 1991. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 19:243-248.
4. Clemens, M. J. 1993. The small RNAs of Epstein-Barr virus. Mol. Biol. Rep. 17:81-92.
5. Condit, R. C. 2001. Principles of virology, p. 19-51. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
6. Eliopoulos, A. G., N. J. Gallagher, S. M. Blake, C. W. Dawson, and L. S. Young. 1999. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274:16085- 16096.
7. Eliopoulos, A. G., M. Stack, C. W. Dawson, K. M. Kaye, L. Hodgkin, S. Sihota, M. Rowe, and L. S. Young. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916.
8. Fok, V., R. M. Mitton-Fry, A. Grech, and J. A. Steitz. 2006. Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 12:872-882.
9. Foy, E., K. Li, R. J. Sumpter, Y. M. Loo, C. L. Johnson, C. Wang, P. M. Fish, M. Yoneyama, T. Fujita, S. M. Lemon, and M. J. Gale. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102:2986- 2991.
10. Glickman, J. N., J. G. Howe, and J. A. Steitz. 1988. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol. 62:902-911.
11. Hutchins, D., B. B. Cohen, and C. M. Steel. 1990. Production and regulation of IL-6 in human B lymphoid cells. Eur. J. Immunol. 20:961-968.
12. Imai, S., J. Nishikawa, and K. Takada. 1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371-4378.
13. Iwakiri, D., Y. Eizuru, M. Tokunaga, and K. Takada. 2003. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 63:7062-7067.
14. Iwakiri, D., T. S. Sheen, J. Y. Chen, D. P. Huang, and K. Takada. 2005. Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24:1767-1773.
15. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28.
16. Kieff, E., and A. B. Rickinson. 2001. Epstein-Barr virus and its replication, p. 2511-2573. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.). Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
17. - RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J. 19:6742-6750.
18. Lerner, M. R., N. C. Andrews, G. Miller, and J. A. Steitz. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 78:805-809.
19. Nakagomi, H., R. Dolcetti, M. T. Bejarano, P. Pisa, R. Kiessling, and M. G. Masucci. 1994. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int. J. Cancer 57:240-244.
20. Nanbo, A., K. Inoue, K. Adachi-Takasawa, and K. Takada. 2002. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J. 21:954-965.
21. Nanbo, A., and K. Takada. 2002. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis. Rev. Med. Virol. 12:321-326.
22. - RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J. Virol. 79:12280-12285.
23. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
24. Rosa, M. D., E. Gottlieb, M. R. Lerner, and J. A. Steitz. 1981. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol. Cell. Biol. 1:785-796.
25. Samanta, M., D. Iwakiri, T. Kanda, T. Imaizumi, and K. Takada. 2006. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25:4207-4214.
26. Sano, M., Y. Kato, and K. Taira. 2006. Sequence-specific interference by small RNAs derived from adenovirus VAI RNA. FEBS Lett. 580:1553-1564.
27. Scala, G., I. Quinto, M. R. Ruocco, A. Arcucci, M. Mallardo, P. Caretto, G. Forní, and S. Venuta. 1990. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. J. Exp. Med. 172:61-68.
28. Shimizu, N., A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada. 1994. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68:6069-6073.
29. Shimizu, N., H. Yoshiyama, and K. Takada. 1996. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J. Virol. 70:7260-7263.
30. Swaminathan, S., B. Tomkinson, and E. Kietf. 1991. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc. Natl. Acad. Sci. USA 88:1546-1550.
31. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
32. Toczyski, D. P., A. G. Matera, D. C. Ward, and J. A. Steitz. 1994. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc. Natl. Acad. Sci. USA 91:3463-3467.
33. Toczyski, D. P., and J. A. Steitz. 1991. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J. 10:459-466.
34. Tosato, G., J. Tanner, K. D. Jones, M. Revel, and S. E. Pike. 1990. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 64:3033-3041.
35. Vockerodt, M., B. Haier, P. Buttgereit, H. Tesch, and D. Kube. 2001. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway. Virology 280:183-198.
36. Yajima, M., T. Kanda, and K. Takada. 2005. Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J. Virol. 79:4298-4307.
37. Yang, L., K. Aozasa, K. Oshimi, and K. Takada. 2004. Epstein-Barr virus (EBV)-encoded RNA (EBER) promotes growth of EBV-infected T-cells through interleukin-9 induction. Cancer Res. 64:5332-5337.
38. Yang, L., S. Maruo, and K. Takada. 2000. CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells. J. Virol. 74:10745-10751.
39. Yokoi, T., T. Miyawaki, A. Yachie, K. Kato, Y. Kasahara, and N. Taniguchi. 1990. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 70:100-105.
40. Yoshiyama, H., N. Shimizu, and K. Takada. 1995. Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J. 14:3706-3711.